Filter Results:
(2,627)
Show Results For
- All HBS Web
(5,417)
- People (17)
- News (1,980)
- Research (2,627)
- Events (4)
- Multimedia (212)
- Faculty Publications (1,911)
Show Results For
- All HBS Web
(5,417)
- People (17)
- News (1,980)
- Research (2,627)
- Events (4)
- Multimedia (212)
- Faculty Publications (1,911)
Sort by
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- 09 Jan 2018
- First Look
First Look at New Research and Ideas, January 9, 2018
head CT order, time from head CT order to head CT scheduled, time from head CT scheduled to head CT completed, and time from head CT completed to head CT preliminary report), each process was the bottleneck 30%, <1%, 27%, and 42% of the time, respectively.... View Details
Keywords: Sean Silverthorne
- 20 Jan 2015
- First Look
First Look: January 20
rededicating themselves to improving the value they deliver to their patients: better outcomes and lower costs. Time-driven activity-based costing offers the potential for clinicians to redesign their care processes toward that end. This... View Details
Keywords: Sean Silverthorne
- 27 May 2014
- First Look
First Look: May 27
Download working paper: http://ssrn.com/abstract=2182628 Government Green Procurement Spillovers: Evidence from Municipal Building Policies in California By: Simcoe, Timothy, and Michael W. Toffel Abstract—We study how government green procurement policies influence... View Details
Keywords: Sean Silverthorne
- 12 Feb 2008
- First Look
First Look: February 12, 2007
Abstract Financial statements are the basis for a wide range of business analysis. Managers, securities analysts, bankers, and consultants all use them to make business decisions. There is strong demand among business students for course... View Details
Keywords: Martha Lagace
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
An online shipping platform that uses social networks and smartphones. Low-cost medical care and monitoring that helps seniors to live at home. The "Skype" of broadband, offering free Internet service. On an April morning known as "Super... View Details
- 05 Jan 2010
- First Look
First Look: January 5
leading center for diabetes care, clinician training, and research. The incidence of diabetes is rising precipitously worldwide, challenging quality of life with its complications and rapidly accelerating health View Details
Keywords: Martha Lagace
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 21 Dec 2010
- First Look
First Look: December 21
insight of that paper, which is that a demand for fairness could lead to different economic systems such as those observed in France versus the U.S. (multiple equilibria). Download the paper: http://www.hbs.edu/research/pdf/11-059.pdf A... View Details
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- 07 Feb 2017
- First Look
First Look at New Research: February 7
https://www.hbs.edu/faculty/Pages/item.aspx?num=52166 Harvard Business School Case 317-034 La-Z-Boy (A) Kurt Darrow, CEO of La-Z-Boy furniture, must decide whether to continue an overhaul of the company's strategy in the face of a collapse in View Details
Keywords: Sean Silverthorne
- March 2023 (Revised March 2024)
- Case
The Purdue Pharma Bankruptcy: Settling the Opioid Crisis
By: Kristin Mugford, Carin-Isabel Knoop and Susan Pinckney
How to get to a fair outcome for claimants in the Purdue Pharma bankruptcy given its significant role in the U.S. opioid crisis. View Details
Keywords: Regulation; Ethics; Fairness; Insolvency and Bankruptcy; Government Legislation; Courts and Trials; Laws and Statutes; Lawsuits and Litigation; Legal Liability; Crime and Corruption; Negotiation Offer; Negotiation Participants; Negotiation Style; Product Design; Product Development; Brands and Branding; Marketing Strategy; Trust; Government and Politics; Law; Negotiation; Operations; Ownership; Marketing; Social Psychology; Health Care and Treatment; Pharmaceutical Industry; United States
Mugford, Kristin, Carin-Isabel Knoop, and Susan Pinckney. "The Purdue Pharma Bankruptcy: Settling the Opioid Crisis." Harvard Business School Case 223-060, March 2023. (Revised March 2024.)
- 27 Mar 2012
- First Look
First Look: March 27
disastrous mistakes that can splinter a founding team, strip founders of control, and leave founders without a financial payoff for their hard work and innovative ideas. He highlights the need at each step to strike a careful balance... View Details
Keywords: Carmen Nobel
- 17 Jan 2017
- Research & Ideas
Can China Maintain Its Economic Power?
engineers—they love to build things, and they are very good at it. Their progress on infrastructure projects in the last couple of decades is remarkable, but in keeping with their natural strength and the will of a one-party government. Meeting the growing View Details
Keywords: by Deborah Blagg
- 15 Dec 2015
- First Look
December 15, 2015
as opposed to an agency cost. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=50200 October 19, 2015 Harvard Business Review Getting Bundled Payments Right in Health Care By: Kaplan, Robert... View Details
Keywords: Carmen Nobel
- 15 Jan 2013
- First Look
First Look: January 15
disruption. Download the paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=43906 Cases & Course MaterialsRomney vs. Obama and U.S. Energy Policy Abdelal, Rawi, and Kaitlyn TuthillHarvard Business School Case 713-050 In 2012, the energy sector in the United States was... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
http://www.hbs.edu/research/pdf/07-011.pdf Cases & Course MaterialsCutlass Capital, L.P. Harvard Business School Case 805-075 David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health View Details
Keywords: Martha Lagace
- December 2007 (Revised July 2009)
- Case
Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?
GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details
Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe
Isenberg, Daniel J. "Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?" Harvard Business School Case 808-033, December 2007. (Revised July 2009.)